Compliance with topical timolol treatment

Area of Science:

• Ophthalmology
• Pharmacology
• Patient Adherence Research

Background:

• Medication non-compliance is a significant challenge in managing chronic eye conditions.
• Previous studies suggested pilocarpine treatment adherence may be lower than other regimens.
• Understanding adherence patterns is crucial for optimizing glaucoma treatment efficacy.

Purpose of the Study:

• To quantify patient compliance with timolol eyedrop treatment.
• To compare compliance rates between timolol and pilocarpine treatments in a subset of patients.
• To investigate factors influencing medication adherence in glaucoma patients.

Main Methods:

• A sample of 110 patients undergoing timolol treatment was monitored using unobtrusive electronic eyedrop dispensers.
• Data on drug administration timing and frequency were collected over a four- to six-week period.
• Compliance was calculated as the percentage of prescribed doses administered.

Main Results:

• Patients administered an average of 82.7% of prescribed timolol doses.
• In patients using both timolol and pilocarpine concurrently, timolol adherence was 84.3% and pilocarpine adherence was 77.7% (P = .012).
• Adherence rates varied significantly, ranging from 20% to 100%.

Conclusions:

• Medication regimen influences patient compliance, but does not eliminate non-adherence.
• Even medications perceived as more convenient or with fewer side effects may not guarantee perfect adherence.
• Strategies to improve medication adherence in glaucoma patients require further investigation beyond drug selection.